The Effect of Targeted Therapy for Genitourinary Malignancies on Sexual Function and Fertility

Bradley C Holland1, Zubin Shetty2, Shaheen Alanee3

  • 1Department of Surgery, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA.

Abstract

Insights

Targeted therapies for genitourinary cancers offer survival benefits but may impact sexual function. mTOR inhibitors may affect testosterone and semen, while tyrosine kinase inhibitors (TKIs) show no adverse sexual outcomes.

Area of Science:

  • Oncology
  • Urology
  • Pharmacology

Background:

  • Targeted therapy use is increasing for genitourinary (GU) cancers.
  • These treatments improve survival but have limited long-term adverse effect data.
  • Quality of life, particularly sexual function, is crucial for long-term cancer survivors.

Purpose of the Study:

  • To review the impact of targeted therapies on sexual function in genitourinary cancer patients.
  • To identify potential adverse sexual effects associated with specific targeted drug classes.
  • To highlight the need for discussing sexual health in cancer care.

Main Methods:

  • Literature review of targeted therapies for GU cancers.
  • Analysis of studies reporting on sexual function outcomes.
  • Examination of drug class-specific effects on sexual health.

Main Results:

  • mTOR inhibitors may affect testosterone levels and semen parameters.
  • Tyrosine kinase inhibitors (TKIs) have not been linked to adverse sexual outcomes in current literature.
  • Laboratory studies suggest potential benefits of tyrosine kinases for erectile function.

Conclusions:

  • Sexual side effects of targeted therapies for GU cancer require careful patient discussion.
  • Further research is needed to elucidate mechanisms and long-term outcomes of sexual function with emerging targeted therapies.

Related Concept Videos

Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
499
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
618
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
51
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.0K
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
527